esther granell hospital de la santa creu i sant pau barcelona. spain [email protected]
DESCRIPTION
NEUROIMAGING IN FXTAS Can we predict conversion of premutation carriers?. Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain [email protected]. BACKGROUND. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/1.jpg)
Esther Granell Hospital de la Santa Creu i Sant PauBarcelona. [email protected]
NEUROIMAGING IN FXTAS Can we predict conversion of premutation carriers?
![Page 2: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/2.jpg)
BACKGROUNDFragile-X-associated Tremor/Ataxia Syndrome (FXTAS) is a late onset neurodegenerative disorder occurrying in carriers of a premutation expansion (55 to 200 repeats) of the Fragile X Mental Retardation (FMR1) gene
![Page 3: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/3.jpg)
BACKGROUNDNORMAL<54 CGG
FULL MUTACION >200 CGG
PREMUTATION55-200 CGG
Fragile X Syndrome (FXS)FMR1 gene RNAm absent protein(methylation) (no transcription)
FMR1 gene RNAm translation FMR1protein
Fragile X Tremor Ataxia Syndrome (FXTAS)FMR1 gene excess RNAm normal or low proteinToxic gain-of-function: inclusion formation and neurological dysfunction
![Page 4: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/4.jpg)
Diagnostic criteriaMajor Radiological: WM, MCP and brainstem hyperintensities
Minor Radiological: brain, WM lesions moderate/severe brain atrophy
Major Clinical: intentional tremor, gait distubances
Minor Clinical:parkinsonism, loss of short memory executive disturbances
Some FXTAS develop cognitive decline and eventually dementia, this having been mainly described in men. Up to date, it remains unknown which carriers will develop FXTAS and cognitive decline late in life
“Definitive” disease: 1 major radiological + 1 major clinical
“Probable”disease: 1 major radiological + 1 minor or 2 major clinical
“Possible disease”: 1 minor + 1 major radiological
![Page 5: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/5.jpg)
PURPOSE To investigate if 3T MRI markers can differentiate
FXTAS from non-FXTAS subjects, which may be potentially useful in predicting conversion of premutation carriers to FXTAS
To evaluate the relationship between MRI markers and cognitive-neuropsychological disturbances
![Page 6: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/6.jpg)
METHODS Prospective, cross-sectional study of 44 subjects (30 premutationcarriers and 14 controls),aged 33-80, matched for age and sex
3T (Philips Intera 2.1) MRI included 3D FLAIR and 3D-T1 MPRAGE. Conventional, previously described MRI findings were assessed by two experienced neuroradiologists
Neurological and neuropsychological evaluations :executive, memory, attention, global intelligence, and conductual
Cortical thickness (Freesurfer) and hippocampal volume (FS) and hippocampal shape (SPHARM) were analyzed on 3D MPRAGE images searching for potential MR markers
Statistical analysis included group-comparisons (Student´s t-test and one-way ANOVA) and a General Lineal Model
![Page 7: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/7.jpg)
MRI findings in FXTAS patients included:
Middle cerebellar peduncle, brainstem, and cerebral white matter hyperintensities
Cerebellar, brainstem and brain atrophy
RESULTS
![Page 8: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/8.jpg)
brain atrophy location MTL a. brainstem a. HI cerebellar a. MCP HI WM HIpremutated ++ F,P,T ++ + + ++ + +++/ cups,dots
premutated + F - - + + + +++ / cups,dots
premutated + F,P - - + + + dots < 20
premutated + F,P - - - + + 6 dots
premutated + F,T,P - + - ++ + cups ,dots > 20
premutated - - - + + + + 2/3 dots
premutated + F,P, ant. T - + ++ ++ + ++ /dots, cups
premutated + F,P - - + + + 2 dots
premutated ++ F,T ++ ++ + +++ ++ ++ / cups,dots
premutated + F,P - + + + + + 3 dots
premutated + - - - / + / -
premutated + F,P - - + + + 2 dots
premutated + Global F,P,T + - + + Slight 1 dot
premutated - - - - - - + 1, 2 dots
premutated ++ F,P - + - ++ + dots
premutated - `- - - - + - -
premutated + F - - - - + 3dots
premutated +++ F,T,P ++ ++ + +++ ++ +++
premutated ++ F,P - + + ++ + + (few)
premutated ++ F,P,T ++ ++ - ++ - -
premutated ++ F,P - ++ + +++ ++ -
![Page 9: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/9.jpg)
brain atrophy location MTL a. brainstem a. HI cerebellar a. MCP HI WM HIpremutated ++ F,P,T ++ + + ++ + +++/ cups,dots
premutated + F - - + + + +++ / cups,dots
premutated + F,P - - + + + dots < 20
premutated + F,P - - - + + 6 dots
premutated + F,T,P - + - ++ + cups ,dots > 20
premutated - - - + + + + 2/3 dots
premutated + F,P, ant. T - + ++ ++ + ++ /dots, cups
premutated + F,P - - + + + 2 dots
premutated ++ F,T ++ ++ + +++ ++ ++ / cups,dots
premutated + F,P - + + + + + 3 dots
premutated + - - - / + / -
premutated + F,P - - + + + 2 dots
premutated + Global F,P,T + - + + Slight 1 dot
premutated - - - - - - + 1, 2 dots
premutated ++ F,P - + - ++ + dots
premutated - `- - - - + - -
premutated + F - - - - + 3dots
premutated +++ F,T,P ++ ++ + +++ ++ +++
premutated ++ F,P - + + ++ + + (few)
premutated ++ F,P,T ++ ++ - ++ - -
premutated ++ F,P - ++ + +++ ++ -
![Page 10: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/10.jpg)
RESULTS 11 patients fulfilled FXTAS-criteria (women and men), 2 women having dementia:
1a 1b 1c
2a 2b 2c
These 2 women having FXTAS and dementia showed predominant frontal and temporal lobe atrophy, and white matter hyperintensities
![Page 11: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/11.jpg)
RESULTS-Cortical thickness There was selective decrease in cortical thickness in frontal and
temporal regions, already present in the premutation state
FXTAS-Elder Pre Elder Pre-Elder ControlYoung Pre-Young Control
![Page 12: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/12.jpg)
Young pre-Young con Elder Pre–Elder con
FXTAS-Elder Pre
LH
Rostralmiddlefrontal 0.00095 0.00027 0.00269
Superiorfrontal 0.00812 0.00046 7.24 × 10-5
Precentral 0.0033 0.0025 0.007
Lateraloccipital 0.0014 0.0027 0.023
Parahippocampal 0.0014 0.0011 0.01
Anteriorcingulate 0.00095 0.0063
Posteriorcingulate 0.00079 0.00085
RH
Superiorfrontal 0.00047 0.00028
Caudalmiddlefrontal 0.0004 0.0079
Inferiorparietal 0.00229
Insula 0.0097 0.0058 0.0097
Anteriorcingulate 0.0032 0.00070 0.0044
Posteriorcingulate 9.7 × 10-6 0.005
Parahippocampal 0.0089
RESULTS-Cortical thickness
![Page 13: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/13.jpg)
RESULTS-Hippocampal volume and shape
Additionally, there were changes in hippocampal volume and its shape in the premutated and FXTAS state, more profound in those patients with dementia.
Hippocampal volume in D FTXAS <non D FXTAS<Elder Pre (p=0.015 and 0.037)
Young pre-Young control FXTAS-Elder pre D FXTAS-non D FXTAS
![Page 14: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/14.jpg)
On neuropsychology, there was evidence of prefrontal and temporal impairment in premutated patients along the disease process
(FrBSe) Frontal System Behavior Scale: Apathy, dishinibition and executive disfunction in premutated patients:Premutated vs Control (Total scale p= 0.021)FXTAS vs Elder pre (Apathy p=0.087)D FXTAS vs. Non-D FXTAS ( Apathy P=0.04)
Left hippocampal cognitive disturbances: AVLT (Auditory Verbal Learning Test)Immediate AVLT: FXTAS vs Premutated (p=0.042) Delayed AVLT: D FXTAS vs non-D FXTAS (p=0.074)
RESULTS-Neuropsychology
![Page 15: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/15.jpg)
CONCLUSION There are MRI changes already
present in the premutated state in the frontal and temporal brain regions
These reflect impairment of related brain functions. 3T MRI may provide biomarkers, which could be clinically useful
![Page 16: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/16.jpg)
REFERENCES I1) Jacquemont, S, et al.Fragile X Premutation Tremor/Ataxia Syndrome: Molecular,
Clinical, and Neuroimaging Correlates. Am. J. Hum. Genet. 72:869–878, 2003
2) Rodriguez-Revenga L, et al. Motor and mental dysfunction in mother-daughter transmitted FXTAS. Neurology 2010 (in press)
3)A. Inagakia, A. Iidab, M. Matsubarac and H. Inagakid. Positron emission tomography and magnetic resonance imaging in spinocerebellar ataxia type 2: a study of symptomatic and asymptomatic individuals. European Journal of Neurology 2005, 12: 725–728
4)M.R.R. Gonçalves, L. P. Capelli, R. Nitrini, E. R. Barbosa, C. S. Porto, L. T. Lucato and A. M. Vianna-Morgante. Atypical clinical course of fxtas: rapidly progressive dementia as the major symptom. Neurology 2007;68;1864-1866
5)S. Jacquemont, R.J Hagerman, P.J Hagerman, M.A Leehey. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol 2007 Jan; 6 (1): 45-55
![Page 17: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/17.jpg)
REFERENCES II5)S. Jacquemont, R.J Hagerman, P.J Hagerman, M.A Leehey. Fragile-X
syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol 2007 Jan; 6 (1): 45-55
6) M. A. Leehey, E. Berry-Kravis, S. Min, D. A. Hall, C. D. Rice, L. Zhang, J. Grigsby, C. M. Greco, A.Reynolds, R. Lara, B J. Cogswell, S. Jacquemont, D.R. Hessl, F. Tassone, R. Hagerman. Progression of Tremor and Ataxia in Male Carriers of the FMR1 Premutation. Movement Disorders 2007; 22 (2): 203-206
7) M.A Leehey, R.P Munnhoz, A.E. Lang, J.A. Brunberg, J. Grigsby, C. Greco, S. Jacquemont, F. Tassone, A.M Lozano, P. Hagerman, RJ Hagerman. The Fragile X Premutation Presenting as Essential Tremor. Arch Neurol Vol 60, Jan 2003: 117-121
8)J. S. Adams, P. E. Adams, D. Nguyen, J. A. Brunberg, F. Tassone, W. Zhang, K. Koldewyn, S. M. Rivera, J. Grigsby, L. Zhang, C. DeCarli, P. J. Hagerman and R. J. Hagerman Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS) Neurology 2007;69;851-859
![Page 18: Esther Granell Hospital de la Santa Creu i Sant Pau Barcelona. Spain egranell@santpau.cat](https://reader035.vdocuments.mx/reader035/viewer/2022070422/568164ca550346895dd6e752/html5/thumbnails/18.jpg)
PIC, IFAE, UAB
• Genetics:M MilaL RodriguezA Sanchez
• Neurology:J PagonabarragaJ KulissevskyE MuñozE Tolosa
• Neuroradiology:B GómezJ RuscalledaM De JuanF Núñez
• Collaborators:
O LopezG LlebariaG MontéG Sanchez M DelfinoY Vives
• Patients and Controls• Hospital Clinic/IDIBAPS• H Santa Creu i Sant Pau
• MR technical staff
Acknowledgements
FIS 07/770